Summary: Startup funding headlines often mask what is really happening beneath the surface. Comparing Q1 2023 with Q1 2025 shows how a handful of AI mega-rounds can make an entire quarter look healthy while early-stage founders struggle to raise capital.
SoftBank led a $40 billion financing for OpenAI, announced March 31, and suddenly a quarterly funding report looks incredible. But peel back that single deal and the picture shifts dramatically. This is not a new trick. Startup funding totals have a habit of misleading you, and comparing two quarters two years apart reveals exactly how the illusion works.
The Headline Number Problem
When you read that North American startup investment hit $82 billion in Q1 2025, the highest in three years, it sounds like a boom. That number is accurate, according to Crunchbase News. But nearly half of it came from one deal. Without context, founders and analysts walk away with the wrong impression about market health.
The same thing happened in Q1 2023. North American funding reached $46.3 billion, down 46% year over year. That sounds like a clear decline. Yet even that weaker number was propped up by two enormous rounds. Without OpenAI's $10 billion round and Stripe's $6.5 billion raise, Q1 2023 venture funding would have been down more than 60% year over year.
Q1 2023: Broad Weakness, Hidden by Two Rounds
In Q1 2023, the pain was widespread. Both seed-stage and early-stage investment were down quarter over quarter, along with reported deal counts. A frozen IPO market and wilted public tech valuations also suppressed later-stage dealmaking.
The $10 billion OpenAI round and $6.5 billion Stripe round acted as a statistical mask. Remove them, and the 46% year-over-year decline becomes something closer to 60%. The overall story is clear: the market was contracting across stages, and two massive deals made it look less severe than it was.
Q1 2025: AI Mega-Rounds Mask Early-Stage Decline
Fast forward to Q1 2025, and the headline number flipped to $82 billion. On paper, a massive recovery. Late- and growth-stage deals for U.S. and Canadian companies totaled $66.4 billion, roughly quadruple year-ago levels and up more than 50% from the prior quarter. Anthropic raised significant funding across multiple rounds. Google planned a $32 billion purchase of Wiz, the largest startup acquisition ever. CoreWeave's IPO raised $1.5 billion.
But early-stage investment told a completely different story. Both early- and seed-stage investment declined. Reported round counts fell across all stages. The $40 billion OpenAI round accounted for nearly half the entire quarterly total.
Head-to-Head: How Mega-Rounds Distort Both Quarters
Both quarters share the same structural problem. In Q1 2023, two rounds worth $16.5 billion turned a 60% decline into a 46% decline. In Q1 2025, one $40 billion round turned a contracting early-stage market into a headline about a three-year funding high.
The difference is direction. Q1 2023 used mega-rounds to soften a clearly declining market. Q1 2025 used a mega-round to invert the narrative entirely, making a quarter with falling seed and early-stage numbers look like a boom. In both cases, the late-stage tail wagged the entire startup dog.
What This Means for Founders and Investors
If you are an early-stage founder, the headline number is noise. What matters is your stage, your sector, and the actual round count in your category. In Q1 2025, early-stage funding fell even as the aggregate number screamed recovery. That disconnect matters for fundraising strategy, hiring plans, and runway calculations.
The next time you see a blockbuster quarterly funding total, ask one question: what does it look like without the top three deals? That simple exercise will give you a more honest read on the market than any headline ever will. Have you noticed this gap between headline funding numbers and what early-stage founders are actually experiencing?
Comments